How can oral paediatric formulations be improved? A challenge for the XXI century.
Sign Up to like & getrecommendations! Published in 2020 at "International journal of pharmaceutics"
DOI: 10.1016/j.ijpharm.2020.119905
Abstract: Paediatric oral formulations need to be improved. This is an indisputable fact that has gain attention from the regulators, the medical staff, and researchers. The lack of adequate medicines developed for children, resulted in several… read more here.
Keywords: paediatric formulations; formulations improved; palatability; improved challenge ... See more keywords
From paediatric formulations development to access: Advances made and remaining challenges
Sign Up to like & getrecommendations! Published in 2022 at "British Journal of Clinical Pharmacology"
DOI: 10.1111/bcp.15293
Abstract: Developing suitable paediatric formulations and ensuring access to them by the greatest number of the 2.2 billion children worldwide are equally important to provide optimal pharmacotherapy. This review focuses on the progress made over the… read more here.
Keywords: development access; paediatric formulations; formulations development; access advances ... See more keywords
OC 8510 BIOTRANSFORMATION OF PRAZIQUANTEL FOR THE PHARMACOKINETIC OPTIMISATION OF PRAZIQUANTEL USE IN MASS DRUG ADMINISTRATION AND DEVELOPMENT OF NEW PAEDIATRIC FORMULATIONS
Sign Up to like & getrecommendations! Published in 2019 at "BMJ Global Health"
DOI: 10.1136/bmjgh-2019-edc.26
Abstract: Background Praziquantel (PZQ) is the only drug available for the treatment of all forms of schistosomiasis. New paediatric formulations for the active enantiomer R-PZQ and the racemate PZQ are currently under development. There is however… read more here.
Keywords: new paediatric; drug; pzq; praziquantel ... See more keywords